Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 38: 2203-2214, 1992;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bodor, G. S.
Right arrow Articles by Ladenson, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bodor, G. S.
Right arrow Articles by Ladenson, J. H.

Clinical Chemistry, Vol 38, 2203-2214, Copyright © 1992 by American Association for Clinical Chemistry

Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction

GS Bodor, S Porter, Y Landt and JH Ladenson
Washington University School of Medicine, Department of Pathology, St. Louis, MO 63110.

To improve the specificity of biochemical markers of myocardial infarction (MI), we have developed a double monoclonal "sandwich" enzyme immunoassay to measure cardiac troponin-I (cTnI) in serum. We produced eight IgG monoclonal antibodies against human cardiac troponin- I (cTnI) and tested them against human and animal (canine, bovine, and rabbit) troponins. Five antibodies were cardiac-specific; none of the antibodies were species-specific. Two of the five cTnI-specific monoclonal antibodies were utilized in an immunoassay. Standards were made by adding purified human cTnI to affinity-stripped cTnI-free human sera to cover the range 0-100 micrograms/L for cTnI. The dose-response curve was nonlinear but reproducible. Total assay imprecision (CV) varied between 11% and 21%. The upper limit of the reference range (nonparametric 95% interval) was established as 3.1 micrograms/L by measuring cTnI concentration in sera of 159 hospitalized patients without evidence of cardiac disease. Purified human skeletal TnI up to 10,000 micrograms/L did not affect the assay (calculated cross- reactivity < 0.1%). Diagnostic sensitivities of creatine kinase MB isoenzyme (CK-MB) and cTnI were evaluated retrospectively in 49 consecutive patients with proven MI. In the 30 patients for whom sufficient information was available to establish an accurate time course, CK-MB was more sensitive during the first 4 h after the onset of chest pain, but thereafter the sensitivities were similar up to 48 h. However, cTnI is more cardiac-specific than is CK-MB and remains increased longer than does CK-MB.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
E. Kuhn, T. Addona, H. Keshishian, M. Burgess, D.R. Mani, R. T. Lee, M. S. Sabatine, R. E. Gerszten, and S. A. Carr
Developing Multiplexed Assays for Troponin I and Interleukin-33 in Plasma by Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry
Clin. Chem., June 1, 2009; 55(6): 1108 - 1117.
[Abstract] [Full Text] [PDF]

Home page
 jvdiHome page
R. Tunca, M. Sozmen, H. Erdogan, M. Citil, E. Uzlu, H. Ozen, and E. Gokce
Determination of cardiac troponin I in the blood and heart of calves with foot-and-mouth disease
J Vet Diagn Invest, September 1, 2008; 20(5): 598 - 605.
[Abstract] [Full Text] [PDF]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
F. Capuano, C. Simon, A. Roscitano, G. Sclafani, E. Tonelli, and R. Sinatra
Cardiac Troponin I Concentrations During On-Pump Coronary Artery Surgery
Asian Cardiovasc Thorac Ann, December 1, 2007; 15(6): 502 - 506.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
NACB WRITING GROUP MEMBERS, D. A. Morrow, C. P. Cannon, R. L. Jesse, L. K. Newby, J. Ravkilde, A. B. Storrow, A. H.B. Wu, and R. H. Christenson
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes
Circulation, April 3, 2007; 115(13): e356 - e375.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
NACB WRITING GROUP MEMBERS, D. A. Morrow, C. P. Cannon, R. L. Jesse, L. K. Newby, J. Ravkilde, A. B. Storrow, A. H.B. Wu, R. H. Christenson, NACB COMMITTEE MEMBERS, et al.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes
Clin. Chem., April 1, 2007; 53(4): 552 - 574.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
Y.-H. Choi, C. Stamm, P. E. Hammer, K. F. Kwaku, J. J. Marler, I. Friehs, M. Jones, C. M. Rader, N. Roy, M.-T. Eddy, et al.
Cardiac Conduction through Engineered Tissue
Am. J. Pathol., July 1, 2006; 169(1): 72 - 85.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
L. Babuin and A. S. Jaffe
Troponin: the biomarker of choice for the detection of cardiac injury
Can. Med. Assoc. J., November 8, 2005; 173(10): 1191 - 1202.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
F. S. Apple and M. M. Murakami
Cardiac Troponin and Creatine Kinase MB Monitoring during In-Hospital Myocardial Reinfarction
Clin. Chem., February 1, 2005; 51(2): 460 - 463.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. Rej
Clinical Chemistry through Clinical Chemistry: A Journal Timeline
Clin. Chem., December 1, 2004; 50(12): 2415 - 2458.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. B. Rosalki, R. Roberts, H. A. Katus, E. Giannitsis, J. H. Ladenson, and F. S. Apple
Cardiac Biomarkers for Detection of Myocardial Infarction: Perspectives from Past to Present
Clin. Chem., November 1, 2004; 50(11): 2205 - 2213.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. Landesberg, V. Shatz, I. Akopnik, Y. G. Wolf, M. Mayer, Y. Berlatzky, C. Weissman, and M. Mosseri
Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery
J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1547 - 1554.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
L. J. Kim, E. A. Martinez, N. Faraday, T. Dorman, L. A. Fleisher, B. A. Perler, G. M. Williams, D. Chan, and P. J. Pronovost
Cardiac Troponin I Predicts Short-Term Mortality in Vascular Surgery Patients
Circulation, October 29, 2002; 106(18): 2366 - 2371.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
D. Cardinale, M. T. Sandri, A. Martinoni, E. Borghini, M. Civelli, G. Lamantia, S. Cinieri, G. Martinelli, C. Fiorentini, and C. M. Cipolla
Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy
Ann. Onc., May 1, 2002; 13(5): 710 - 715.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. S. Raman, R. Bellomo, M. Hayhoe, M. Tsamitros, and B. F. Buxton
Metabolic changes and myocardial injury during cardioplegia: a pilot study
Ann. Thorac. Surg., November 1, 2001; 72(5): 1566 - 1571.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
P. Boknik, I. Heinroth-Hoffmann, U. Kirchhefer, J. Knapp, B. Linck, H. Luss, T. Muller, W. Schmitz, O.-E. Brodde, and J. Neumann
Enhanced protein phosphorylation in hypertensive hypertrophy
Cardiovasc Res, September 1, 2001; 51(4): 717 - 728.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. Landesberg, M. Mosseri, D. Zahger, Y. Wolf, M. Perouansky, H. Anner, B. Drenger, Y. Hasin, Y. Berlatzky, and C. Weissman
Myocardial infarction after vascular surgery: the role of prolonged, stress-induced, ST depression-type ischemia
J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1839 - 1845.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. M. Hoogerwaard, Y. Schouten, A. J. van der Kooi, J. P.M.C. Gorgels, M. de Visser, and G. T.B. Sanders
Troponin T and Troponin I in Carriers of Duchenne and Becker Muscular Dystrophy with Cardiac Involvement
Clin. Chem., May 1, 2001; 47(5): 962 - 963.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Hammerer-Lercher, P. Erlacher, R. Bittner, R. Korinthenberg, D. Skladal, S. Sorichter, W. Sperl, B. Puschendorf, and J. Mair
Clinical and Experimental Results on Cardiac Troponin Expression in Duchenne Muscular Dystrophy
Clin. Chem., March 1, 2001; 47(3): 451 - 458.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. C.J.M. Swaanenburg, B. G. Loef, M. Volmer, P. W. Boonstra, J. G. Grandjean, M. A. Mariani, and A. H. Epema
Creatine Kinase MB, Troponin I, and Troponin T Release Patterns after Coronary Artery Bypass Grafting with or without Cardiopulmonary Bypass and after Aortic and Mitral Valve Surgery
Clin. Chem., March 1, 2001; 47(3): 584 - 587.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
P. Boknik, S. Khorchidi, G. S. Bodor, S. Huke, J. Knapp, B. Linck, H. Luss, F. U. Muller, W. Schmitz, and J. Neumann
Role of protein phosphatases in regulation of cardiac inotropy and relaxation
Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H786 - H794.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
D. A. Morrow, E. M. Antman, M. Tanasijevic, N. Rifai, J. A. de Lemos, C. H. McCabe, C. P. Cannon, and E. Braunwald
Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy
J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1812 - 1817.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
S. Dixit, M. Castle, R. P. Velu, L. Swisher, C. Hodge, and A. S. Jaffe
Cardiac Involvement in Patients With Acute Neurologic Disease: Confirmation With Cardiac Troponin I
Arch Intern Med, November 13, 2000; 160(20): 3153 - 3158.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. Wayand, H. Baum, G. Schatzle, J. Scharf, and D. Neumeier
Cardiac Troponin T and I in End-Stage Renal Failure
Clin. Chem., September 1, 2000; 46(9): 1345 - 1350.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
D. Cardinale, M. T. Sandri, A. Martinoni, A. Tricca LabTech, M. Civelli, G. Lamantia, S. Cinieri, G. Martinelli, C. M. Cipolla, and C. Fiorentini
Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy
J. Am. Coll. Cardiol., August 1, 2000; 36(2): 517 - 522.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Covinsky, O. Laterza, J. D. Pfeifer, T. Farkas-Szallasi, and M. G. Scott
An IgM {lambda} Antibody to Escherichia coli Produces False-Positive Results in Multiple Immunometric Assays
Clin. Chem., August 1, 2000; 46(8): 1157 - 1161.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
C. A. Labarrere, D. R. Nelson, C. J. Cox, D. Pitts, P. Kirlin, and H. Halbrook
Cardiac-Specific Troponin I Levels and Risk of Coronary Artery Disease and Graft Failure Following Heart Transplantation
JAMA, July 26, 2000; 284(4): 457 - 464.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
C. A. Polanczyk, K. M. Kuntz, D. B. Sacks, P. A. Johnson, and T. H. Lee
Emergency Department Triage Strategies for Acute Chest Pain Using Creatine Kinase-MB and Troponin I Assays: A Cost-Effectiveness Analysis
Ann Intern Med, December 21, 1999; 131(12): 909 - 918.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. Datta, K. Foster, and A. Dasgupta
Comparison of Immunoreactivity of Five Human Cardiac Troponin I Assays toward Free and Complexed Forms of the Antigen: Implications for Assay Discordance
Clin. Chem., December 1, 1999; 45(12): 2266 - 2269.
[Full Text] [PDF]

Home page
 Vasc MedHome page
D. B Sacks
Acute coronary ischemia: troponin I and T
Vascular Medicine, November 1, 1999; 4(4): 253 - 256.
[Abstract] [PDF]

Home page
 J Am Coll CardiolHome page
M. J. Tanasijevic, C. P. Cannon, E. M. Antman, D. R. Wybenga, G. A. Fischer, C. Grudzien, C. M. Gibson, J. W. Winkelman, E. Braunwald, and for the TIMI 10B Investigators
Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: Results from the thrombolysis in myocardial infarction study (TIMI) 10B
J. Am. Coll. Cardiol., September 1, 1999; 34(3): 739 - 747.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. J. Newman, Y. Olabiran, W. D. Bedzyk, S. Chance, E. G. Gorman, and C. P. Price
Impact of Antibody Specificity and Calibration Material on the Measure of Agreement between Methods for Cardiac Troponin I
Clin. Chem., June 1, 1999; 45(6): 822 - 828.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. Manuel del Rey, A. H. Madrid, J. M. Valino, J. Rubi, J. Mercader, C. Moro, and E. Ripoll
Cardiac troponin I and minor cardiac damage: biochemical markers in a clinical model of myocardial lesions
Clin. Chem., November 1, 1998; 44(11): 2270 - 2276.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. H. Christenson and H. M. E. Azzazy
Biochemical markers of the acute coronary syndromes
Clin. Chem., August 1, 1998; 44(8): 1855 - 1864.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
O. Hetland and K. Dickstein
Cardiac troponins I and T in patients with suspected acute coronary syndrome: a comparative study in a routine setting
Clin. Chem., July 1, 1998; 44(7): 1430 - 1436.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
L. Coudrey
The Troponins
Arch Intern Med, June 8, 1998; 158(11): 1173 - 1180.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. H. B. Wu, Y.-J. Feng, R. Moore, F. S. Apple, P. H. McPherson, K. F. Buechler, G. Bodor, f. t. A. A. for, and C. C. S. o. c. Standardization
Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I
Clin. Chem., June 1, 1998; 44(6): 1198 - 1208.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
O. Hetland and K. Dickstein
Cardiac Troponin T by Elecsys System and a Rapid ELISA: Analytical Sensitivity in Relation to the TropT (CardiacT) ""Bedside"" Test
Clin. Chem., June 1, 1998; 44(6): 1348 - 1350.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. Ferrieres, C. Calzolari, J.-C. Mani, D. Laune, S. Trinquier, M. Laprade, C. Larue, B. Pau, and C. Granier
Human cardiac troponin I: precise identification of antigenic epitopes and prediction of secondary structure
Clin. Chem., March 1, 1998; 44(3): 487 - 493.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. H. Christenson, S.-H. Duh, L. K. Newby, E. M. Ohman, R. M. Califf, C. B. Granger, S. Peck, K. S. Pieper, P. W. Armstrong, H. A. Katus, et al.
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes
Clin. Chem., March 1, 1998; 44(3): 494 - 501.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Fredericks, G. Merton, M.-J. Lerena, D. W. Holt, G. S. Bodor, F. S. Apple, and E. M. Voss
Markers of Myocardial Damage
Clin. Chem., February 1, 1998; 44(2): 362 - 365.
[Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
V. Sadony, M. Korber, G. Albes, V. Podtschaske, T. Etgen, T. Trosken, U. Ravens, and M. E. Scheulen
Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery
Eur. J. Cardiothorac. Surg., January 1, 1998; 13(1): 57 - 65.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
S. A. Wright, D. B. Sawyer, D. B. Sacks, and S. Z. Goldhaber
Elevation of Troponin I Levels in Patients Without Evidence of Myocardial Injury
JAMA, December 24, 1997; 278(24): 2144 - 2144.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
P. J. O'Brien, Y. Landt, and J. H. Ladenson
Differential reactivity of cardiac and skeletal muscle from various species in a cardiac troponin I immunoassay
Clin. Chem., December 1, 1997; 43(12): 2333 - 2338.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. S. Luscher, K. Thygesen, J. Ravkilde, and L. Heickendorff
Applicability of Cardiac Troponin T and I for Early Risk Stratification in Unstable Coronary Artery Disease
Circulation, October 21, 1997; 96(8): 2578 - 2585.
[Abstract] [Full Text]

Home page
 CirculationHome page
G. S. Bodor, A. E. Oakeley, P. D. Allen, D. L. Crimmins, J. H. Ladenson, and P. A. W. Anderson
Troponin I Phosphorylation in the Normal and Failing Adult Human Heart
Circulation, September 2, 1997; 96(5): 1495 - 1500.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
A. G. Katrukha, A. V. Bereznikova, T. V. Esakova, K. Pettersson, T. Lovgren, M. E. Severina, K. Pulkki, L.-M. Vuopio-Pulkki, and N. B. Gusev
Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex
Clin. Chem., August 1, 1997; 43(8): 1379 - 1385.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. D. McLaurin, F. S. Apple, E. M. Voss, C. A. Herzog, and S. W. Sharkey
Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle
Clin. Chem., June 1, 1997; 43(6): 976 - 982.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
V. Ricchiuti, J. Zhang, and F. S. Apple
Cardiac troponin I and T alterations in hearts with severe left ventricular remodeling
Clin. Chem., June 1, 1997; 43(6): 990 - 995.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. Lozano, P. Carreno, I. Moreno, and M. Mendez
Analytical Performance of the Sanofi Access(R) Cardiac Troponin-I Procedure
Clin. Chem., June 1, 1997; 43(6): 1088 - 1089.
[Full Text] [PDF]

Home page
 CirculationHome page
S. C. Smith, J. H. Ladenson, J. W. Mason, and A. S. Jaffe
Elevations of Cardiac Troponin I Associated With Myocarditis: Experimental and Clinical Correlates
Circulation, January 7, 1997; 95(1): 163 - 168.
[Abstract] [Full Text]

Home page
 NEJMHome page
E. M. Antman, M. J. Tanasijevic, B. Thompson, M. Schactman, C. H. McCabe, C. P. Cannon, G. A. Fischer, A. Y. Fung, C. Thompson, D. Wybenga, et al.
Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes
N. Engl. J. Med., October 31, 1996; 335(18): 1342 - 1349.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
F. Van de Werf
Cardiac Troponins in Acute Coronary Syndromes
N. Engl. J. Med., October 31, 1996; 335(18): 1388 - 1389.
[Full Text]

Home page
 JAMAHome page
T. M. Guest, A. V. Ramanathan, P. G. Tuteur, K. B. Schechtman, J. H. Ladenson, and A. S. Jaffe
Myocardial Injury in Critically Ill Patients: A Frequently Unrecognized Complication
JAMA, June 28, 1995; 273(24): 1945 - 1949.
[Abstract] [PDF]

Home page
 NEJMHome page
J. E. Adams, G. A. Sicard, B. T. Allen, K. H. Bridwell, L. G. Lenke, V. G. Davila-Roman, G. S. Bodor, J. H. Ladenson, and A. S. Jaffe
Diagnosis of Perioperative Myocardial Infarction with Measurement of Cardiac Troponin I
N. Engl. J. Med., March 10, 1994; 330(10): 670 - 674.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Association for Clinical Chemistry.